Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
Authors
Keywords
Resiquimod, Thermosensitive liposomes, Immunotherapy, Breast cancer, αPD-1
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 330, Issue -, Pages 1080-1094
Publisher
Elsevier BV
Online
2020-11-13
DOI
10.1016/j.jconrel.2020.11.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial
- (2019) Michael D. Gray et al. RADIOLOGY
- Clinical Trials of Thermosensitive Nanomaterials: An Overview
- (2019) Stefania Nardecchia et al. Nanomaterials
- Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study
- (2019) Cédric Thauvin et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Combining activatable nanodelivery with immunotherapy in a murine breast cancer model
- (2019) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator
- (2019) Ruolin Lu et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-specific delivery of gemcitabine with activatable liposomes
- (2019) Samantha T. Tucci et al. JOURNAL OF CONTROLLED RELEASE
- Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles
- (2018) Ana Isabel Bocanegra Gondan et al. BIOMATERIALS
- Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
- (2018) Hyunjoon Kim et al. BIOMATERIALS
- Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery
- (2018) Wei-Lun Tang et al. BIOMATERIALS
- Recent advances in ultrasound-triggered therapy
- (2018) Chaopin Yang et al. JOURNAL OF DRUG TARGETING
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
- (2018) Matthew J. Frank et al. Cancer Discovery
- Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer
- (2018) Lu Zhang et al. NANO LETTERS
- Trial Watch: Toll-like receptor agonists in cancer immunotherapy
- (2018) Melody Smith et al. OncoImmunology
- A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
- (2017) E J Cheadle et al. LEUKEMIA
- Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes
- (2017) Wei-Lun Tang et al. MOLECULAR PHARMACEUTICS
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model
- (2017) Dong Gao et al. Journal of Cancer
- Anti-tumor Activity of Toll-Like Receptor 7 Agonists
- (2017) Huju Chi et al. Frontiers in Pharmacology
- The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
- (2017) Carlene Petes et al. Frontiers in Immunology
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
- (2016) Nazila Kamaly et al. CHEMICAL REVIEWS
- Strategies for designing synthetic immune agonists
- (2016) Tom Y.-H. Wu IMMUNOLOGY
- A Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer
- (2016) Wei-Lun Tang et al. PHARMACEUTICAL RESEARCH
- Development of a spherically focused phased array transducer for ultrasonic image-guided hyperthermia
- (2016) Jingfei Liu et al. PHYSICS IN MEDICINE AND BIOLOGY
- Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy
- (2016) Simon J. Dovedi et al. Oncotarget
- Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells
- (2016) S. J. Dovedi et al. Cancer Immunology Research
- A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice
- (2016) Gabriela Maria Wiedemann et al. OncoImmunology
- TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
- (2016) Thibaud Spinetti et al. OncoImmunology
- Current clinical trials testing the combination of immunotherapy with radiotherapy
- (2016) Josephine Kang et al. Journal for ImmunoTherapy of Cancer
- Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma
- (2015) I. Sagiv-Barfi et al. BLOOD
- CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery
- (2015) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma
- (2015) Jiang Zhu et al. Journal of Hematology & Oncology
- Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model
- (2015) TAO YIN et al. Molecular Medicine Reports
- One Step Encapsulation of Small Molecule Drugs in Liposomes via Electrospray-Remote Loading
- (2015) Anthony D. Duong et al. MOLECULAR PHARMACEUTICS
- Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
- (2015) Sebastian Schölch et al. Oncotarget
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
- (2015) R. L. Sabado et al. Cancer Immunology Research
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Toll-like receptors as therapeutic targets for cancer
- (2013) Johanna Holldack DRUG DISCOVERY TODAY
- Liposomal resiquimod for the treatment of Leishmania donovani infection
- (2013) K. J. Peine et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia
- (2013) Azadeh Kheirolomoom et al. JOURNAL OF CONTROLLED RELEASE
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- How can grafted breast cancer models be optimized?
- (2011) Séverine Mollard et al. CANCER BIOLOGY & THERAPY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
- (2011) Abbi L Engel et al. Expert Review of Clinical Pharmacology
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
- (2010) Yong Zhang et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Structure of Hepatitis E Virion-sized Particle Reveals an RNA-dependent Viral Assembly Pathway
- (2010) Li Xing et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12
- (2010) David A. Zaharoff et al. JOURNAL OF IMMUNOTHERAPY
- Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
- (2010) Azadeh Kheirolomoom et al. MOLECULAR PHARMACEUTICS
- Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid
- (2009) Stefan Hupfeld et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
- (2008) J. K. Miller et al. CANCER RESEARCH
- A review of stimuli-responsive nanocarriers for drug and gene delivery
- (2008) Srinivas Ganta et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now